MedTrace Logo

Sarcopenic Obesity in Neurodisabilities

NCT03863379 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-01-27

No results posted yet for this study

Summary

To describe the frequency and thresholds for sarcopenic obesity in neurodisabled persons and the fat and lean mass distribution based on various neurodisabilities

Conditions

Interventions

DIAGNOSTIC_TEST

whole body DXA

Measurements of body composition may be used to study how lean body mass and body fat change during health and disease and have provided a research tool to study the metabolic effects of obesity and various wasting conditions. DXA measurements are based in part on the assumption that the hydration of fat-free mass remains constant at 73%.

Sponsors & Collaborators

  • University of Athens

    collaborator OTHER

  • University of Patras

    collaborator OTHER

  • Dionyssiotis, Yannis, M.D.

    lead INDIV

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-02
Primary Completion
2021-06-15
Completion
2022-05-15

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03863379 on ClinicalTrials.gov